Ключевые слова:
Иммуногистокимёвий текшириш, эндотелий ўсиш омили, ўткир коронар синдром, ишемия, миокард, стеноз, некробиоз, дистрофия.Библиографические ссылки
Zhang Y., Cao H., Jiang P., Tang H. Cardiac rehabilitation in acute myocardial infarction patients after percutaneous coronary intervention: A community-based study // Medicine (Baltimore). – 2018. – 97(8). – e9785.
Zhang Y., Liu Y., Liu H., Tang W.H. Exosomes: biogenesis, biologic function and clinical potential // Cell Biosci. – 2019. – 9. – P.19.
Zhang Y., Pfaffle R., Blankenstein O., Hildebrand P. Molecular mechanisms of non-familial hypercholesterolemia // J Mol Med (Berl). – 2020. – 98(9). – P.1241-1253.
Zhao Q.M., Feng T.T., Zhao X., et al. Use of cardioprotective medications among patients with coronary artery disease in China: Results from the improving Care for Cardiovascular Disease in China-Coronary artery disease (CCC-CAD) study // J Am Heart Assoc. – 2019. – 8(17). – e011496.
Zheng Z., Jayaram R., Jiang L., et al. Perioperative Rosuvastatin in Cardiac Surgery // N Engl J Med. – 2016. – 374(18). – P.1744-1753.
Zhou J., Austin R.C. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms // Biofactors. – 2009. – 35(2). – P.120-129.
Zhou L., Niu J.M., Jiang H.K. An atherogenic diet promotes macrophage infiltration into the sinoatrial node of the murine heart // Int J Mol Med. – 2017. – 39(5). – P.1355-1360.
Zhou M., Ren H., Han J., et al. Inflammatory proteins are associated with severity of coronary artery disease in patients with non-ST-elevation myocardial infarction during high-sensitivity troponin era // J Thorac Dis. – 2020. – 12(4). – P.1343-1352.
Zhuang J., Peng W., Liu H., Lin Y., Huang W., Xu J. Coronary bifurcation treatments with the provisional strategy in the past decade: A pooled analysis of 1,404 patients // Medicine (Baltimore). – 2017. – 96(51). – e9251.
Ziegelstein R.C., Fauerbach J.A., Stevens S.S., Romanelli J., Richter D.P., Bush D.E. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction // Arch Intern Med. – 2000. – 160(12). – P.1818-1823.
Zwakenberg S.R., den Braver N.R., Engelen A.I.P., et al. Vitamin K intake and all-cause and cause specific mortality // Clin Nutr. – 2017. – 36(5). – P.1294-1300.
Wang X., Khalil R.A. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease // Adv Pharmacol. – 2018. – 81. – P.241-330.
Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis // Arterioscler Thromb Vasc Biol. – 1995. – 15(5). – P.551-561
Winchester D.E., Pepine C.J. Angina treatments and prevention of cardiac events: an appraisal of the evidence // Eur Heart J Suppl. – 2015. – 17(Suppl G). – P.G10-G18.
Witztum J.L., Lichtman A.H. The influence of innate and adaptive immune responses on atherosclerosis // Annu Rev Pathol. – 2014. – 9. – P.73-102.
Wolf D., Ley K. Immunity and Inflammation in Atherosclerosis // Circ Res. – 2019. – 124(2). – P.315-327.
Wong N.D. Epidemiological studies of CHD and the evolution of preventive cardiology // Nat Rev Cardiol. – 2014. – 11(5). – P.276-289.
Yao X., Smolka G., Wawrzynska M., Franz N., Neunteufl T., Leung S.W. Interventional therapy for acute myocardial infarction: Primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention // Heart Lung Circ. – 2017. – 26(7). – P.748-755.